Skip to main content
Caplight Logo









SafeTide

SafeTide

Private
CambridgeHealthcare & Life Scienceshttps://kingselab.org

Last Round

Accelerator

Aug 20, 2025

Company Overview

SafeTide operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was an Accelerator round in August 2025.

SafeTide is a biotechnology company developing low-cost stabilisation technology to keep delicate medicines like insulin stable at room temperature.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

SafeTide Comparables

Compare SafeTide with similar companies based on industry and business-model similarity.

SafeTide comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnsiliTech
86%
DuraVax Inc.
81%
Jurata Thin Film
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

SafeTide Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 20, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

SafeTide Investors

Notable investors and investment history

SafeTide investors
InvestorRounds
Founders at the University of CambridgeAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2025

    Received funding from Founders at the University of Cambridge.

Book a demo to see all signals

For institutional investors. Book with your work email.

SafeTide Filings

Explore SEC and related filing metadata, where available.

SafeTide filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about SafeTide's valuation, stock price, and market status.

Is SafeTide a public or private company?

SafeTide is a private company.

What is the current stock price of SafeTide?

SafeTide is a private company, so its shares have no public market price. Caplight tracks SafeTide's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SafeTide worth (valuation)?

Valuation information for SafeTide is not publicly available.

Can I buy SafeTide stock?

SafeTide shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SafeTide's last funding round?

SafeTide's most recent funding round was Accelerator on August 20, 2025.

Who are the main investors in SafeTide?

Key investors in SafeTide include Founders at the University of Cambridge.

Will SafeTide IPO soon?

No public IPO plans have been announced for SafeTide.

How can I track SafeTide secondary market activity?

Caplight tracks bids, offers, and trades in SafeTide's shares on secondary markets.

Firmographic Details

HeadquartersCambridge
Year Founded2025
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?